Here's Shares Agios Pharmaceuticals: 2026 Outlook and Rally
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
Tax lots affect cost basis and gains in retirement accounts. This piece compares ETFs and mutual funds to help you choose.
25,093 articlesBiotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
As tensions flare, Qatar’s plan to buy $4 billion in Patriot missiles reshapes security and markets. This article bre...
A historic step: Paxos earns SEC clearance to operate as a registered clearing agency. This milestone could reshape c...
A deep dive into applied digital's stunning rally, the backlog fueling demand, and the tough questions investors must...
The nuclear energy story 2026 is taking shape as decarbonization and power-hungry data demand push expansion. This gu...
As power demand climbs, nuclear energy offers reliable baseload power and steady dividends. Here are three nuclear st...
SpaceX's $7.7 billion AI infrastructure push in Q1 2026 marks a dramatic shift from traditional rocket business to da...
On Tuesday morning, Lockheed Martin stock dropped sharply before trimming losses. This deep dive explains the mix of ...
Costco’s price action has moved back toward the $1,000 level, prompting a careful look at whether the stock deserves ...
Oracle leads data center stocks this week as AI cloud momentum outpaces rivals CoreWeave and Applied Digital in a vol...
Defense markets are shifting as missiles that changed balance drive bigger budgets and stronger stock moves. This rep...
Micron stock has surged dramatically, but savvy investors are asking: is it still a bargain? This article breaks down...